Ajax loader
By using our website, you agree to our use of cookies as described in Cookie Policy.

Can't find what you're looking for?

 

Be sure to Sign in to see all available content.

 

If you don't have an account, Register here.

Search results for:

MEDICINES-EUROPE/BIOSIMILARS
RTXSWNO
October 01, 2010
European Medicines Agency (EMA) Executive Director Thomas Lonngren poses for a portrait before an interview...
London, United Kingdom
To match Interview MEDICINES-EUROPE/BIOSIMILARS
European Medicines Agency (EMA) Executive Director Thomas Lonngren poses for a portrait before an interview with Reuters at his office in London, October 1, 2010. European regulators will spell out requirements for copies of antibody drugs next month, paving the way for generic competition in a multibillion-dollar market that includes treatments for cancer and immune system disorders. European Medicines Agency (EMA) Executive Director Thomas Lonngren told Reuters on Friday that guidelines on biosimilar monoclonal antibodies would be published after being reviewed by the agency's expert committee on drug approvals in November. To match Interview MEDICINES-EUROPE/BIOSIMILARS REUTERS/Simon Newman (BRITAIN - Tags: BUSINESS HEALTH)
Sort by
Display
Items per page
Page
of 1